YS | YS Biopharma Co., Ltd. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.9000 - 1.1000
52 Week Range	0.3503 - 1.7800
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	102,955
Average Volume	130,559
Shares Outstanding	188,328,000
Market Cap	192,094,560
Sector	Healthcare
Industry	Biotechnology
IPO Date	2021-08-05

Valuation
Profitability
Growth
Health
P/E Ratio	-1.82
Forward P/E Ratio	N/A
EPS	-0.56
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	773
Country	China
Website	YS

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

YS's peers: MYMD, PHGE, SONN, SPRC, XBIO

*Chart delayed

Analyzing fundamentals for YS we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see YS Fundamentals page.

Watching at YS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on YS Technicals page.